PANNA is the name of the study of Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA). The purpose of the study is to collect pharmacokinetic data (PK curves) in pregnant HIV-infected women using newly developed antiretroviral agents.

European network

Prof. Dr. David Burger and Dr. Angela Colbers (Department of Pharmacy, Radboud university medical center, Nijmegen, The Netherlands) set up a European network of European centres who are participating in this study. Dr. Colbers is the coordinator of the PANNA study and network.

This website gives information about the study, how physicians can include patients and how centres can participate in the PANNA study.